Health In Tech reported revenue of $8.10M and net income of -$2.51M for the quarter ended Jun 2026, down 9.3% year over year. This income statement covers 10 quarters of results from Dec 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||
| Revenue | 5.21M | 5.00M | 4.46M | 5.00M | 8.93M | 9.58M | 9.93M | 9.12M | 8.10M | |
| Cost of RevenueCost of Rev | 0.99M | 0.97M | 0.98M | 1.11M | 2.66M | 3.00M | 3.35M | 3.38M | 4.13M | |
| Gross Profit | 4.14M | 4.03M | 3.48M | 3.80M | 5.36M | 6.31M | 5.14M | 4.13M | 3.92M | |
| Operating items | ||||||||||
| Research & DevelopmentR&D | 1.04M | 0.97M | 0.72M | 0.63M | 1.09M | 1.23M | 0.96M | 0.91M | 2.22M | |
| Selling, General & AdministrativeSG&A | 2.00M | 1.82M | 1.81M | 2.85M | 3.25M | 3.78M | 3.45M | 3.18M | 4.27M | |
| Other Operating ExpensesOther Opex | 0.76M | 0.70M | 0.51M | 0.63M | 0.54M | 0.58M | 0.24M | 0.21M | 0.88M | |
| Operating ExpensesOpex | 3.80M | 3.49M | 3.04M | 4.11M | 4.87M | 5.58M | 4.65M | 4.30M | 7.36M | |
| Operating IncomeOp. Inc | 0.33M | 0.53M | 0.44M | -0.32M | 0.48M | 0.73M | 0.49M | -0.17M | -3.44M | |
| EBIT | 0.33M | 0.53M | 0.44M | -0.32M | 0.48M | 0.73M | 0.49M | -0.17M | -3.44M | |
| Non-operating items | ||||||||||
| Non Operating Interest Expenses | 0.17M | 0.17M | 0.17M | 0.01M | 0.38M | 0.05M | ||||
| Interest & Investment IncomeInt & Inv Inc | 0.02M | 0.03M | 0.04M | 0.03M | 0.09M | 0.11M | 0.11M | 0.10M | 0.07M | |
| Other Non Operating IncomeOther Non Op Inc. | 0.16M | 0.11M | 0.12M | 0.10M | ||||||
| Non Operating IncomeNon Op. Inc. | -0.14M | -0.13M | -0.03M | 0.21M | 0.20M | 0.11M | 0.11M | -0.27M | 0.12M | |
| Net income details | ||||||||||
| EBT | 0.19M | 0.40M | 0.41M | -0.11M | 0.68M | 0.83M | 0.60M | -0.44M | -3.32M | |
| Tax ProvisionsTaxes | 0.15M | 0.06M | 0.06M | 0.04M | 0.22M | 0.23M | 0.15M | -0.20M | -0.81M | |
| Profit After TaxPAT | 0.10M | 0.34M | 0.38M | -0.14M | 0.50M | 0.63M | 0.45M | -0.30M | -2.51M | |
| Income from Non-Controlling InterestsInc. Minority | 0.00M | |||||||||
| Income from Continuing OperationsIncome (Continuing) | 0.04M | 0.34M | 0.35M | -0.15M | 0.46M | 0.60M | 0.45M | -0.25M | -2.51M | |
| Consolidated Net IncomeConsol Net Inc. | 0.04M | 0.34M | 0.35M | -0.15M | 0.46M | 0.60M | 0.45M | -0.25M | -2.51M | |
| Income towards Parent CompanyParent Net Inc | 0.04M | 0.34M | 0.35M | -0.15M | 0.46M | 0.60M | 0.45M | -0.25M | -2.51M | |
| Net Income towards Common StockholdersNet Income | 0.04M | 0.34M | 0.35M | -0.15M | 0.46M | 0.60M | 0.45M | -0.25M | -2.51M | |
| Additional items | ||||||||||
| EPS (Basic) | 0.00 | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | -0.04 | |
| EPS (Diluted) | 0.00 | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | -0.04 | |
| Shares Outstanding | 47.84M | 51.77M | 51.77M | 51.77M | 51.84M | 54.62M | 55.38M | 56.43M | 55.84M | 62.83M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 47.84M | 51.77M | 51.77M | 51.77M | 53.66M | 57.00M | 55.63M | 58.77M | 57.74M | 62.83M |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 103.54M | 51.77M | 51.77M | 51.77M | 106.45M | 54.62M | 56.39M | 56.43M | 59.96M | 65.56M |
| EBITDA | 0.33M | 0.53M | 0.44M | -0.32M | 0.48M | 0.73M | 0.49M | -0.17M | -3.44M | |
| Interest ExpensesInt Expense | 0.17M | 0.17M | 0.17M | 0.01M | 0.38M | 0.05M | ||||
| Tax Rate | 78.89% | 15.77% | 14.34% | -35.86% | 32.19% | 28.17% | 24.67% | 43.96% | 24.39% |